000 | 01906 a2200517 4500 | ||
---|---|---|---|
005 | 20250516014231.0 | ||
264 | 0 | _c20110329 | |
008 | 201103s 0 0 eng d | ||
022 | _a1998-4774 | ||
024 | 7 |
_a10.4103/0019-509X.73558 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBahl, A | |
245 | 0 | 0 |
_aSynchronous carcinoma breast with chronic myelogenous leukemia: a rare presentation. _h[electronic resource] |
260 |
_bIndian journal of cancer _c |
||
300 |
_a477-9 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBenzamides |
650 | 0 | 4 |
_aBreast Neoplasms _xpathology |
650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xpathology |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 | _aDocetaxel |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 | _aIn Situ Hybridization, Fluorescence |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xpathology |
650 | 0 | 4 | _aMastectomy |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms, Multiple Primary _xpathology |
650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
650 | 0 | 4 | _aRadiotherapy |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aSelective Estrogen Receptor Modulators _xadministration & dosage |
650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
700 | 1 | _aDhiman, A | |
700 | 1 | _aTalwar, V | |
700 | 1 | _aDoval, D C | |
773 | 0 |
_tIndian journal of cancer _gvol. 47 _gno. 4 _gp. 477-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4103/0019-509X.73558 _zAvailable from publisher's website |
999 |
_c20423093 _d20423093 |